Software / Technology Platform · +4 more types
Products: GastroPlus, MonolixSuite +9 more
“Using population-based pharmacokinetic models, we can characterize drug disposition using sparse drug concentration data in patients with the condition of interest, whereas…”Source: simulations-plus.com
Also offers: Model-Informed Drug Development (MIDD), PBPK Modeling, +2 more
CRO / Research Services Provider · +2 more types
Products: ClinQuick
“Population PK/PD modeling is another key tool for extracting more understanding from clinical studies with sparse sampling in patients and special populations. Modeling and…”Source: celerion.com
Also offers: First-in-Human (Phase I) Clinical Pharmacology Support, Clinical Trial Bioanalytical & Biomarker Testing, +2 more
Service Provider · +2 more types
Products: D.AI.M.I.
“Non-compartmental analysis (NCA) and population PK/PD modeling”Source: plglifesciences.com
Also offers: Regulatory Development Strategy & Agency Interactions, End-to-End Pharmacovigilance Outsourcing, +6 more
CRO / Research Services Provider · +7 more types
Products: IQVIA Vigilance Platform, SmartSolve +4 more
“Gain support in your label claims and special populations studies with our expert PK modeling.”Source: iqvia.com
Also offers: Full-Service Clinical Trial Execution (CRO Services), Real-World Data Platform, +6 more
| Vendor | Delivery model | Also offers | In their words |
|---|---|---|---|
| Celerion | CRO / Research Services Provider | Clinical PK/PD Analysis | “Population PK/PD modeling is another key tool for extracting more understanding from clinical studies with sparse sampling in patients and special populations…”celerion.com · reviewed Oct 20, 2026 |
| IQVIA | CRO / Research Services Provider | Clinical PK/PD Analysis | “Gain support in your label claims and special populations studies with our expert PK modeling.”iqvia.com · reviewed Oct 15, 2026 |
| ProductLife Group | Service Provider | Clinical PK/PD Analysis | “Non-compartmental analysis (NCA) and population PK/PD modeling”plglifesciences.com · reviewed Oct 26, 2026 |
| Simulations Plus | Software / Technology Platform | Clinical PK/PD Analysis | “Using population-based pharmacokinetic models, we can characterize drug disposition using sparse drug concentration data in patients with the condition of…”simulations-plus.com · reviewed Oct 26, 2026 |